Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Ampio Pharmaceuticals, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Ampio Pharmaceuticals, Inc. | d227339d10q.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - Ampio Pharmaceuticals, Inc. | d227339dex312.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - Ampio Pharmaceuticals, Inc. | d227339dex311.htm |
Exhibit 32.1
AMPIO PHARMACEUTICALS, INC. AND SUBSIDIARIES
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended September 30, 2011 (the “Report”) by Ampio Pharmaceuticals, Inc. (the “Company”), each of the undersigned hereby certifies that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: November 1, 2011 | /S/ DONALD B. WINGERTER, JR. | |
| Donald B. Wingerter, Jr. Chief Executive Officer | ||
| Dated: November 1, 2011 | /s/ Mark D. McGregor | |
| Mark D. McGregor Chief Financial Officer | ||